A Pilot Study on Impact of RTA405 on Glomerular Filtration Rate (GFR) in Type II Diabetic Rats: Phase I

StatusFinished
Effective start/end date1/07/11 → 30/09/12

Funding

  • Reata Pharmaceuticals, Inc.: $137,680.32
View all
View less

Keywords

  • Diabetes, Obesity, & Metabolic Syndrome